EP0725838A4 - Strukturierte synthetische antigenbanken als diagnostika, impfstoffe und therapeutische mittel - Google Patents

Strukturierte synthetische antigenbanken als diagnostika, impfstoffe und therapeutische mittel

Info

Publication number: EP0725838A4
Authority: EP; European Patent Office
Prior art keywords: vaccines; therapeutics; diagnostics; synthetic antigen; structured synthetic
Prior art date: 1993-10-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP94932048A

Other languages

English (en)

French (fr)

Other versions

EP0725838A1 (de

Inventor

Chang Yi Wang

Timothy J Zamb

John Ye

Stephen M Kaminsky

Barbara Hosein

Douglas F Nixon

C Wayne Koff

Jacek Kowalski

Alan M Walfield

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

United Biomedical Inc

Original Assignee

United Biomedical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-26

Filing date

1994-10-26

Publication date

1997-02-26

1994-10-26 Application filed by United Biomedical Inc filed Critical United Biomedical Inc

1996-08-14 Publication of EP0725838A1 publication Critical patent/EP0725838A1/de

1997-02-26 Publication of EP0725838A4 publication Critical patent/EP0725838A4/de

Status Withdrawn legal-status Critical Current

Links

108010008038 Synthetic Vaccines Proteins 0.000 title 1
239000003814 drug Substances 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Virology (AREA)
Analytical Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

EP94932048A 1993-10-26 1994-10-26 Strukturierte synthetische antigenbanken als diagnostika, impfstoffe und therapeutische mittel Withdrawn EP0725838A4 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US14341293A	1993-10-26	1993-10-26
US143412		1993-10-26
PCT/US1994/012268 WO1995011998A1 (en)	1993-10-26	1994-10-26	Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics

Publications (2)

Publication Number	Publication Date
EP0725838A1 EP0725838A1 (de)	1996-08-14
EP0725838A4 true EP0725838A4 (de)	1997-02-26

Family

ID=22503951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP94932048A Withdrawn EP0725838A4 (de)	1993-10-26	1994-10-26	Strukturierte synthetische antigenbanken als diagnostika, impfstoffe und therapeutische mittel

Country Status (5)

Country	Link
EP (1)	EP0725838A4 (de)
AU (1)	AU8091694A (de)
CA (1)	CA2175579A1 (de)
IL (1)	IL111417A0 (de)
WO (1)	WO1995011998A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996007910A1 (en) *	1994-09-02	1996-03-14	Meiji Milk Products Company Limited	Diagnostic drug for chlamydia infection
WO1996012186A1 (en) *	1994-10-14	1996-04-25	Chiron Mimotopes Pty. Ltd.	Method and apparatus for efficient mimotope discovery
GB2294690B (en) *	1994-11-01	1998-10-28	United Biomedical Inc	Peptides effective for diagnosis and detection of hepatitis C infection
DE69610310T2 (de) *	1995-06-02	2001-03-15	M&E Biotech A/S, Horsholm	Verfahren zur identifikation von biologisch aktiven peptiden und nukleinsäuren
AU725609C (en)	1995-08-18	2002-01-03	Morphosys Ag	Protein/(poly)peptide libraries
DE19540105C1 (de) *	1995-09-19	1997-02-20	United Biomedical Inc	Peptidzusammensetzungen zur Diagnose und zum Nachweis von Hepatitis C Virus (HCV)-Infektion
AU7247896A (en) *	1995-09-29	1997-04-17	Scripps Research Institute, The	Protein signature analysis
DE69722176T2 (de)	1996-01-23	2004-03-18	The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto	Verfahren zur suche nach transdominanten effektorpeptiden und rna-molekülen
US6365344B1 (en)	1996-01-23	2002-04-02	The Board Of Trustees Of The Leland Stanford Junior University	Methods for screening for transdominant effector peptides and RNA molecules
IL121115A (en) *	1997-06-19	2001-06-14	Savyon Diagnostics Ltd	C. trachomatis specific peptides and their use in diagnostic assays
IL121114A (en) *	1997-06-19	2001-03-19	Savyon Diagnostics Ltd	C pneumoniae specific peptides and their use in diagnostic assays
US6090388A (en) *	1998-06-20	2000-07-18	United Biomedical Inc.	Peptide composition for prevention and treatment of HIV infection and immune disorders
TWI229679B (en)	1998-06-20	2005-03-21	United Biomedical Inc	Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
US6025468A (en) *	1998-06-20	2000-02-15	United Biomedical, Inc.	Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides
US6107021A (en) *	1998-06-20	2000-08-22	United Biomedical, Inc.	Synthetic peptide vaccines for foot-and-mouth disease
PT1100922E (pt) *	1998-07-31	2008-05-30	Gundersen Lutheran Medical Fou	Utilização do(s) epítopo(s) borrelicida(s) da proteína de superfície externa c (ospc) de borrelia burgdorferi, como vacina
WO2001036614A2 (de)	1999-11-16	2001-05-25	Geneart Gmbh Gessellschaft Für Angewandte Biotechnologie	Das genom des hiv-1 intersubtyps (c/b') und seine anwendungen
BR0001717B1 (pt) *	2000-05-04	2013-10-08		Vacina sintética para o controle de carrapatos
FR2809402A1 (fr) *	2000-05-26	2001-11-30	Dev Des Antigenes Combinatoire	Bibliotheques peptidiques combinatoires convergentes et leur application a la vaccination contre le virus de l'hepatite c
US6780969B2 (en) *	2000-12-22	2004-08-24	United Biomedical, Inc.	Synthetic peptide composition as immunogens for prevention of urinary tract infection
EP1229045A1 (de)	2001-02-01	2002-08-07	Institut Curie	Universeller Träger zum Zielrichten von Molekülen zu Rezeptor Gb3 - exprimierenden Zellen
US6906169B2 (en)	2001-05-25	2005-06-14	United Biomedical, Inc.	Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
ATE292144T1 (de) *	2002-08-02	2005-04-15	Inst Curie	Shiga-toxin-untereinheit b als vektor zur diagnose von tumoren und zur arzneimittelverabreichung an gb3-exprimierenden tumoren
RU2237065C2 (ru) *	2002-10-03	2004-09-27	Государственный научный центр вирусологии и биотехнологии "Вектор"	Иммуногенная библиотека химерных пептидов, мимикрирующая генетическое многообразие гипервариабельного района v3 белка оболочки gp120 вируса иммунодефицита человека
EP2397552A1 (de)	2004-07-28	2011-12-21	National Research Council Of Canada	Rekombinante Impfstoffe gegen caligide Copepoden (Seeläuse) und Antigensequenzen davon
SG171481A1 (en) *	2005-01-03	2011-06-29	Hoffmann La Roche	Hemopexin-like structure as polypeptide-scaffold
EP2361930A3 (de)	2007-03-26	2011-10-26	Dako Denmark A/S	Multimere von peptide-mhc komplexen und deren verwendung in borrelia infektionskrankheiten
EP3620465B1 (de)	2007-07-03	2025-02-19	Dako Denmark A/S	Verbesserte verfahren zur herstellung, markierung und verwendung von mhc-multimeren
US10611818B2 (en)	2007-09-27	2020-04-07	Agilent Technologies, Inc.	MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
DK2254592T3 (da)	2008-02-28	2019-09-09	Dako Denmark As	MHC-multimerer til Borrelia-diagnostik og sygdom
US10722562B2 (en)	2008-07-23	2020-07-28	Immudex Aps	Combinatorial analysis and repair
GB0817244D0 (en)	2008-09-20	2008-10-29	Univ Cardiff	Use of a protein kinase inhibitor to detect immune cells, such as T cells
US11992518B2 (en)	2008-10-02	2024-05-28	Agilent Technologies, Inc.	Molecular vaccines for infectious disease
WO2010037402A1 (en)	2008-10-02	2010-04-08	Dako Denmark A/S	Molecular vaccines for infectious disease
SG175407A1 (en)	2009-05-29	2011-11-28	Morphosys Ag	A collection and methods for its use
CN103068837B (zh)	2010-05-28	2015-06-24	斯匹遐生物技术公司	嵌合momp抗原、方法和使用
RU2603080C2 (ru)	2010-11-19	2016-11-20	МорфоСис АГ	Коллекция и способы ее применения
HK1200359A1 (zh) *	2011-09-17	2015-08-07	源道隆（苏州）医学科技有限公司	任意三个或以上氨基酸残基构成的多肽表位及其相关抗体的诱导
US10660951B2 (en) *	2012-09-17	2020-05-26	Zhiwei Allen Wu	Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof
AU2012394394A1 (en)	2012-11-16	2015-06-04	United Biomedical, Inc.	Synthetic peptide-based emergency vaccine against foot and mouth disease (FMD)
US9102752B2 (en)	2013-03-15	2015-08-11	United Biomedical, Inc.	Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type
MX395464B (es)	2014-07-25	2025-03-25	United Biomedical Inc	Composicion de lhrh inmunogenica y uso de la misma en cerdos.
US12258373B2 (en)	2018-12-17	2025-03-25	Immudex Aps	Panel comprising Borrelia MHC multimers

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992009300A1 (en) *	1990-11-21	1992-06-11	Iterex Pharmaceuticals Ltd. Partnership	Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
EP0639584A1 (de) *	1993-06-22	1995-02-22	Interpharm Laboratories Ltd.	Herstellung und Auswahlverfahren von hochunterschiedlichen Peptidbanken mit Beziehung zur Bindungsfähigkeit

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5106726A (en) *	1990-02-16	1992-04-21	United Biomedical, Inc.	Synthetic peptides specific for the detection of antibodies to HCV

1994
- 1994-10-26 WO PCT/US1994/012268 patent/WO1995011998A1/en not_active Ceased
- 1994-10-26 EP EP94932048A patent/EP0725838A4/de not_active Withdrawn
- 1994-10-26 AU AU80916/94A patent/AU8091694A/en not_active Abandoned
- 1994-10-26 CA CA002175579A patent/CA2175579A1/en not_active Abandoned
- 1994-10-27 IL IL11141794A patent/IL111417A0/xx unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992009300A1 (en) *	1990-11-21	1992-06-11	Iterex Pharmaceuticals Ltd. Partnership	Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
EP0639584A1 (de) *	1993-06-22	1995-02-22	Interpharm Laboratories Ltd.	Herstellung und Auswahlverfahren von hochunterschiedlichen Peptidbanken mit Beziehung zur Bindungsfähigkeit

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A FURKA ET AL.: "General method for rapid synthesis of multicomponent peptide mixtures", INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, vol. 37, no. 1, January 1991 (1991-01-01), COPENHAGEN DK, pages 487 - 493, XP000206365 *
See also references of WO9511998A1 *

Also Published As

Publication number	Publication date
EP0725838A1 (de)	1996-08-14
CA2175579A1 (en)	1995-05-04
WO1995011998A1 (en)	1995-05-04
IL111417A0 (en)	1994-12-29
AU8091694A (en)	1995-05-22

Legal Events

Date	Code	Title	Description
1996-06-28	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1996-08-14	17P	Request for examination filed	Effective date: 19960424
1996-08-14	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1997-02-26	A4	Supplementary search report drawn up and despatched	Effective date: 19970107
1997-02-26	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1997-05-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
1997-06-11	18W	Application withdrawn	Withdrawal date: 19970401
1997-06-25	R18W	Application withdrawn (corrected)	Effective date: 19970403

Publication	Publication Date	Title
IL111417A0 (en)	1994-12-29	Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
US5669731B1 (en)	1999-10-12	Component retaining legs
HU9601574D0 (en)	1996-07-29	Humanized antibodies and uses thereof
EP0647439A3 (de)	1997-04-23	Poröse Gegenstände und Verfahren zu ihrer Herstellung.
HUP9901901A3 (en)	2000-03-28	Vaccines against hepatitis c
GB9416347D0 (en)	1994-10-05	Altered antibodies, products and processes relating thereto
ZA94242B (en)	1994-09-30	Two-way high-leg recliner
GB9412166D0 (en)	1994-08-10	Retargetting antibodies
GB9307369D0 (en)	1993-06-02	Recliner
IL109445A0 (en)	1994-07-31	Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
GB9325496D0 (en)	1994-02-16	Vaccines
ZA966801B (en)	1997-03-14	Antigenic preparations
ZA9610102B (en)	1998-02-18	Salmonella vaccines.
EP0456727A4 (en)	1992-01-15	Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof
EP0622450A3 (de)	1997-02-19	Waschmittel und Verfahren zu deren Herstellung.
DE69513047D1 (de)	1999-12-02	Rückenstütze
ZA9610510B (en)	1998-06-15	Novel peptides, the preparation and use thereof.
ZA947661B (en)	1995-07-07	Vaccines and diagnostics.
EP0681480A4 (de)	1997-06-25	Recognin vakzine.
EP0667395A4 (de)	1996-07-03	Monoklonale antikörper, anwendung und verfahren zur herstellung.
GB2314560B (en)	1999-09-29	Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use
GB2267148B (en)	1996-12-04	Footrot antigens,vaccines and diagnostic assays
GB2302827B (en)	1998-12-30	Laboratory furniture
GB9503867D0 (en)	1995-04-19	Vaccines and diagnostics
IL104767A0 (en)	1993-06-10	Antigenic epitopes and antibodies against them